These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33753222)

  • 1. Value of routine whole genome sequencing for Mycobacterium tuberculosis drug resistance detection.
    Lam C; Martinez E; Crighton T; Furlong C; Donnan E; Marais BJ; Sintchenko V
    Int J Infect Dis; 2021 Dec; 113 Suppl 1():S48-S54. PubMed ID: 33753222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia.
    Chaidir L; Ruesen C; Dutilh BE; Ganiem AR; Andryani A; Apriani L; Huynen MA; Ruslami R; Hill PC; van Crevel R; Alisjahbana B
    J Glob Antimicrob Resist; 2019 Mar; 16():170-177. PubMed ID: 30172045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing.
    Jajou R; van der Laan T; de Zwaan R; Kamst M; Mulder A; de Neeling A; Anthony R; van Soolingen D
    J Antimicrob Chemother; 2019 Sep; 74(9):2605-2616. PubMed ID: 31119271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
    Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
    PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversified lineages and drug-resistance profiles of clinical isolates of
    Noorizhab Fakhruzzaman MN; Abidin NZ; Aziz ZA; Lim WF; Richard JJ; Noorliza MN; Hani MH; Norhayati R; Zamzurina AB; Farida Zuraina MY; Hisyam MJ; Teh LK; Norazmi MN; Zaki MS
    Int J Mycobacteriol; 2019; 8(4):320-328. PubMed ID: 31793500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Park J; Shin SY; Kim K; Park K; Shin S; Ihm C
    Ann Lab Med; 2018 Jul; 38(4):316-323. PubMed ID: 29611381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
    Nonghanphithak D; Kaewprasert O; Chaiyachat P; Reechaipichitkul W; Chaiprasert A; Faksri K
    PLoS One; 2020; 15(12):e0244829. PubMed ID: 33382836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda.
    Ssengooba W; Meehan CJ; Lukoye D; Kasule GW; Musisi K; Joloba ML; Cobelens FG; de Jong BC
    Infect Genet Evol; 2016 Jun; 40():8-16. PubMed ID: 26917365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
    Laurent S; Zakham F; Bertelli C; Merz L; Nicod L; Mazza-Stalder J; Greub G; Jaton K; Opota O
    Int J Antimicrob Agents; 2020 Aug; 56(2):106068. PubMed ID: 32603684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
    Al-Mutairi NM; Ahmad S; Mokaddas EM
    Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-genome sequencing analysis of multidrug-resistant
    Tania T; Sudarmono P; Kusumawati RL; Rukmana A; Pratama WA; Regmi SM; Kaewprasert O; Chaiprasert A; Chongsuvivatwong V; Faksri K
    J Med Microbiol; 2020 Jul; 69(7):1013-1019. PubMed ID: 32579102
    [No Abstract]   [Full Text] [Related]  

  • 14. Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan.
    Ali A; Hasan Z; McNerney R; Mallard K; Hill-Cawthorne G; Coll F; Nair M; Pain A; Clark TG; Hasan R
    PLoS One; 2015; 10(2):e0117771. PubMed ID: 25719196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
    Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
    Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi- and Extensively Drug Resistant Mycobacterium tuberculosis in South Africa: a Molecular Analysis of Historical Isolates.
    Maningi NE; Daum LT; Rodriguez JD; Said HM; Peters RPH; Sekyere JO; Fischer GW; Chambers JP; Fourie PB
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29514936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting.
    Andres S; Gröschel MI; Hillemann D; Merker M; Niemann S; Kranzer K
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of drug resistance mutations in Mycobacterium tuberculosis isolates from North India by whole-genome sequencing.
    Sethi S; Hao Y; Brown SM; Walker T; Yadav R; Zaman K; Aggarwal AN; Behera D
    J Glob Antimicrob Resist; 2020 Mar; 20():11-15. PubMed ID: 31121336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-genome sequencing and single nucleotide polymorphisms in multidrug-resistant clinical isolates of Mycobacterium tuberculosis from the Philippines.
    Roa MB; Tablizo FA; Morado EKD; Cunanan LF; Uy IDC; Ng KCS; Manalastas-Cantos KG; Reyes JM; Ganchua SKC; Ang CF; Kato-Maeda M; Cattamanchi A; Karaoz U; Destura RV; Lluisma AO
    J Glob Antimicrob Resist; 2018 Dec; 15():239-245. PubMed ID: 30130640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar.
    Aung HL; Tun T; Moradigaravand D; Köser CU; Nyunt WW; Aung ST; Lwin T; Thinn KK; Crump JA; Parkhill J; Peacock SJ; Cook GM; Hill PC
    J Glob Antimicrob Resist; 2016 Sep; 6():113-117. PubMed ID: 27530852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.